Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

@article{Lucchinetti2000HeterogeneityOM,
  title={Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination},
  author={C. Lucchinetti and W. Br{\"u}ck and J. Parisi and B. Scheithauer and Moses Rodriguez and H. Lassmann},
  journal={Annals of Neurology},
  year={2000},
  volume={47}
}
Multiple sclerosis (MS) is a disease with profound heterogeneity in clinical course, neuroradiological appearance of the lesions, involvement of susceptibility gene loci, and response to therapy. [...] Key Method From a large pathology sample of MS, collected in three international centers, we selected 51 biopsies and 32 autopsies that contained actively demyelinating lesions defined by stringent criteria.Expand
Clinical implications of neuropathological findings in multiple sclerosis
  • W. Brück
  • Biology, Medicine
  • Journal of Neurology
  • 2005
Pathology of Multiple Sclerosis: Where Do We Stand?
MS: is it one disease?
Pathological heterogeneity of idiopathic central nervous system inflammatory demyelinating disorders.
  • C. Lucchinetti
  • Medicine
  • Current topics in microbiology and immunology
  • 2008
Neuropathology of multiple sclerosis—new concepts
Lessons from the neuropathology of atypical forms of multiple sclerosis
The spectrum of multiple sclerosis: new lessons from pathology
Persistence of immunopathological and radiological traits in multiple sclerosis.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 53 REFERENCES
Patterns of oligodendroglia pathology in multiple sclerosis.
Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination
Monocyte/macrophage differentiation in early multiple sclerosis lesions
...
1
2
3
4
5
...